316 related articles for article (PubMed ID: 33045281)
1. COVID-19 risk stratification algorithms based on sTREM-1 and IL-6 in emergency department.
Van Singer M; Brahier T; Ngai M; Wright J; Weckman AM; Erice C; Meuwly JY; Hugli O; Kain KC; Boillat-Blanco N
J Allergy Clin Immunol; 2021 Jan; 147(1):99-106.e4. PubMed ID: 33045281
[TBL] [Abstract][Full Text] [Related]
2. Validation of sTREM-1 and IL-6 based algorithms for outcome prediction of COVID-19.
Van Singer M; Brahier T; Koch J; Hugli PO; Weckman AM; Zhong K; Kain TJ; Leligdowicz A; Bernasconi E; Ceschi A; Parolari S; Vuichard-Gysin D; Kain KC; Albrich WC; Boillat-Blanco N
BMC Infect Dis; 2023 Sep; 23(1):630. PubMed ID: 37752433
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Accuracy of Soluble Triggering Receptor Expressed on Myeloid Cells (sTREM-1)-based Algorithms in Febrile Adults Presenting to Tanzanian Outpatient Clinics.
Richard-Greenblatt M; Boillat-Blanco N; Zhong K; Mbarack Z; Samaka J; Mlaganile T; Kazimoto T; D'acremont V; Kain KC
Clin Infect Dis; 2020 Mar; 70(7):1304-1312. PubMed ID: 31102510
[TBL] [Abstract][Full Text] [Related]
4. Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19.
de Nooijer AH; Grondman I; Lambden S; Kooistra EJ; Janssen NAF; Kox M; Pickkers P; Joosten LAB; van de Veerdonk FL; Derive M; Gibot S; Netea MG;
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34195785
[TBL] [Abstract][Full Text] [Related]
5. sTREM-1 Predicts Disease Severity and Mortality in COVID-19 Patients: Involvement of Peripheral Blood Leukocytes and MMP-8 Activity.
da Silva-Neto PV; de Carvalho JCS; Pimentel VE; Pérez MM; Toro DM; Fraga-Silva TFC; Fuzo CA; Oliveira CNS; Rodrigues LC; Argolo JGM; Carmona-Garcia I; Neto NT; Souza COS; Fernandes TM; Bastos VAF; Degiovani AM; Constant LF; Ostini FM; Feitosa MR; Parra RS; Vilar FC; Gaspar GG; da Rocha JJR; Feres O; Frantz FG; Gerlach RF; Maruyama SR; Russo EMS; Viana AL; Fernandes APM; Santos IKFM; Bonato VLD; Boechat AL; Malheiro A; Sadikot RT; Dias-Baruffi M; Cardoso CRB; Faccioli LH; Sorgi CA; On Behalf Of The Imunocovid Study Group
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960790
[TBL] [Abstract][Full Text] [Related]
6. sTREM-1 predicts intensive care unit and 28-day mortality in cancer patients with severe sepsis and septic shock.
Ravetti CG; Moura AD; Vieira ÉL; Pedroso ÊR; Teixeira AL
J Crit Care; 2015 Apr; 30(2):440.e7-13. PubMed ID: 25541104
[TBL] [Abstract][Full Text] [Related]
7. IL-6-based mortality risk model for hospitalized patients with COVID-19.
Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
[TBL] [Abstract][Full Text] [Related]
8. Circulating sTREM-1 as a predictive biomarker of pediatric multisystemic inflammatory syndrome (MIS-C).
Gonçalves GS; Correa-Silva S; Zheng Y; Avelar I; Montenegro MM; Ferreira AEF; Bain V; Fink TT; Suguita P; Astley C; Lindoso L; Martins F; Matsuo OM; Ferreira JCOA; Firigato I; de Toledo Gonçalves F; Fernanda B Pereira M; Artur A da Silva C; Carneiro-Sampaio M; Marques HHS; Palmeira P
Cytokine; 2023 Jan; 161():156084. PubMed ID: 36403563
[TBL] [Abstract][Full Text] [Related]
9. TREM-1, TREM-2 and their association with disease severity in patients with COVID-19.
Fan R; Cheng Z; Huang Z; Yang Y; Sun N; Hu B; Hou P; Liu B; Huang C; Liu S
Ann Med; 2023; 55(2):2269558. PubMed ID: 37848000
[TBL] [Abstract][Full Text] [Related]
10. sTREM-1 predicts mortality in hospitalized patients with infection in a tropical, middle-income country.
Wright SW; Lovelace-Macon L; Hantrakun V; Rudd KE; Teparrukkul P; Kosamo S; Liles WC; Limmathurotsakul D; West TE
BMC Med; 2020 Jul; 18(1):159. PubMed ID: 32605575
[TBL] [Abstract][Full Text] [Related]
11. Significance of sTREM-1 in early prediction of ventilator-associated pneumonia in neonates: a single-center, prospective, observational study.
Zhao X; Xu L; Yang Z; Sun B; Wang Y; Li G; Feng C; Pan T; Yu T; Feng X
BMC Infect Dis; 2020 Jul; 20(1):542. PubMed ID: 32711473
[TBL] [Abstract][Full Text] [Related]
12. Development and External Validation of a Machine Learning Tool to Rule Out COVID-19 Among Adults in the Emergency Department Using Routine Blood Tests: A Large, Multicenter, Real-World Study.
Plante TB; Blau AM; Berg AN; Weinberg AS; Jun IC; Tapson VF; Kanigan TS; Adib AB
J Med Internet Res; 2020 Dec; 22(12):e24048. PubMed ID: 33226957
[TBL] [Abstract][Full Text] [Related]
13. Endocan and Soluble Triggering Receptor Expressed on Myeloid Cells-1 as Novel Markers for Neonatal Sepsis.
Saldir M; Tunc T; Cekmez F; Cetinkaya M; Kalayci T; Fidanci K; Babacan O; Erdem G; Kocak N; Sari E; Akgul EO; Kul M
Pediatr Neonatol; 2015 Dec; 56(6):415-21. PubMed ID: 26341458
[TBL] [Abstract][Full Text] [Related]
14. Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19.
Saji R; Nishii M; Sakai K; Miyakawa K; Yamaoka Y; Ban T; Abe T; Ohyama Y; Nakajima K; Hiromi T; Matsumura R; Suzuki N; Taniguchi H; Otsuka T; Oi Y; Ogawa F; Uchiyama M; Takahashi K; Iwashita M; Kimura Y; Fujii S; Furuya R; Tamura T; Ryo A; Takeuchi I
PLoS One; 2021; 16(8):e0256022. PubMed ID: 34379684
[TBL] [Abstract][Full Text] [Related]
15. Prospective validation study of prognostic biomarkers to predict adverse outcomes in patients with COVID-19: a study protocol.
Tang B; Shojaei M; Wang Y; Nalos M; Mclean A; Afrasiabi A; Kwan TN; Kuan WS; Zerbib Y; Herwanto V; Gunawan G; Bedognetti D; Zoppoli G; Ballestrero A; Rinchai D; Cremonesi P; Bedognetti M; Matejovic M; Karvunidis T; Macdonald SPJ; Cox AJ; West NP; Cripps AW; Schughart K; Maria A; Chaussabel D; Iredell J; Weng S;
BMJ Open; 2021 Jan; 11(1):e044497. PubMed ID: 33408218
[TBL] [Abstract][Full Text] [Related]
16. Rapid identification of SARS-CoV-2-infected patients at the emergency department using routine testing.
Kurstjens S; van der Horst A; Herpers R; Geerits MWL; Kluiters-de Hingh YCM; Göttgens EL; Blaauw MJT; Thelen MHM; Elisen MGLM; Kusters R
Clin Chem Lab Med; 2020 Aug; 58(9):1587-1593. PubMed ID: 32598302
[TBL] [Abstract][Full Text] [Related]
17. Elevated Plasma Soluble Triggering Receptor Expressed on Myeloid Cells-1 Level in Patients with Acute Coronary Syndrome (ACS): A Biomarker of Disease Severity and Outcome.
Shiber S; Kliminski V; Orvin K; Sagy I; Vaturi M; Kornowski R; Drescher M; Molad Y
Mediators Inflamm; 2021; 2021():8872686. PubMed ID: 33814983
[TBL] [Abstract][Full Text] [Related]
18. Revised Triage and Surveillance Protocols for Temporary Emergency Department Closures in Tertiary Hospitals as a Response to COVID-19 Crisis in Daegu Metropolitan City.
Chung HS; Lee DE; Kim JK; Yeo IH; Kim C; Park J; Seo KS; Park SY; Kim JH; Kim G; Lee SH; Cheon JJ; Kim YH
J Korean Med Sci; 2020 May; 35(19):e189. PubMed ID: 32419401
[TBL] [Abstract][Full Text] [Related]
19. The role of soluble thrombomodulin in the risk stratification and prognosis evaluation of septic patients in the emergency department.
Yin Q; Liu B; Chen Y; Zhao Y; Li C
Thromb Res; 2013 Oct; 132(4):471-6. PubMed ID: 24035044
[TBL] [Abstract][Full Text] [Related]
20. Elevated plasma level of soluble triggering receptor expressed on myeloid cells-1 is associated with inflammation activity and is a potential biomarker of thrombosis in primary antiphospholipid syndrome.
Edel Y; Kliminski V; Pokroy-Shapira E; Oren S; Dortort Lazar A; Pri-Paz Basson Y; Egbaria M; Molad Y
Arthritis Res Ther; 2019 Jan; 21(1):10. PubMed ID: 30616644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
